For instance, inactivating rearrangements or deletions in IRF-1 have been reported in AML [70], and LOH of this gene has been observed in gastric and esopharyngeal cancers and renal cell carcinoma [99]. The gene discussed is IRF1; the disease is acute myeloid leukemia.